Publications by authors named "Xavier Palard"

Claim this Profile
P
Parkinson-like neurotoxicity in female patients treated with idecabtagene-vicleucel.
Audrey Couturier, Martine Escoffre, Frédérique Leh, Anne-Sophie Villoteau, Xavier Palard

Hemasphere· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial.
Etienne Garin, Lambros Tselikas, Boris Guiu, Julia Chalaye, Yan Rolland, Xavier Palard

J Nucl Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study).
Etienne Garin, Xavier Palard, Yan Rolland, Samuel Le Sourd, Nicolas Lepareur

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validation.
Jens M Theysohn, Aydin Demircioglu, Malte Kleditzsch, Johannes M Ludwig, Manuel Weber, Xavier Palard

Sci Rep· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trans-arterial Radioembolization Dosimetry in 2022.
Etienne Garin, Boris Guiu, Julien Edeline, Yan Rolland, Xavier Palard

Cardiovasc Intervent Radiol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-FDG PET/CT-Based Prognostic Survival Model After Surgery for Head and Neck Cancer.
Gwenaelle Creff, Franck Jegoux, Xavier Palard, Adrien Depeursinge, Ronan Abgral

J Nucl Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective internal radiation therapy in older patients with hepatocellular carcinoma: a retrospective analysis.
Soraya Benguerfi, Florian Estrade, Céline Lescure, Yan Rolland, Xavier Palard

Eur J Gastroenterol Hepatol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular Carcinoma.
Céline Lescure, Florian Estrade, Maud Pedrono, Boris Campillo-Gimenez, Samuel Le Sourd, Xavier Palard

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
Etienne Garin, Lambros Tselikas, Boris Guiu, Julia Chalaye, Julien Edeline, Xavier Palard

Lancet Gastroenterol Hepatol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphocytes and Neutrophil-to-Lymphocyte Ratio Variations After Selective Internal Radiation Treatment for HCC: A Retrospective Cohort Study.
Florian Estrade, Céline Lescure, Léa Muzellec, Maud Pedrono, Xavier Palard

Cardiovasc Intervent Radiol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalised Dosimetry in Radioembolisation for HCC: Impact on Clinical Outcome and on Trial Design.
Etienne Garin, Xavier Palard, Yan Rolland

Cancers (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with Re-SSS Lipiodol radioembolization.
Kostas Delaunay, Julien Edeline, Yan Rolland, Nicolas Lepareur, Sophie Laffont, Xavier Palard

Eur J Nucl Med Mol Imaging· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience.
Héloïse Bourien, Xavier Palard, Yan Rolland, Fanny Le Du, Luc Beuzit

Eur J Nucl Med Mol Imaging· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and Y-loaded glass microsphere selective internal radiation therapy.
Vincent Manceau, Xavier Palard, Yan Rolland, March Pracht, Samuel Le Sourd

Eur J Nucl Med Mol Imaging· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma.
Xavier Palard, Julien Edeline, Yan Rolland, Samuel Le Sourd, Marc Pracht

Eur J Nucl Med Mol Imaging· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional value of combining low-dose computed tomography to V/Q SPECT on a hybrid SPECT-CT camera for pulmonary embolism diagnosis.
Pierre-Yves Le Roux, Philippe Robin, Aurélien Delluc, Ronan Abgral, Xavier Palard

Nucl Med Commun· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interest of chest X-ray in tailoring the diagnostic strategy in patients with suspected pulmonary embolism.
Philippe Robin, Pierre-Yves Le Roux, Valentin Tissot, Aurélien Delluc, Alexandra Le Duc-Pennec, Xavier Palard

Blood Coagul Fibrinolysis· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymmetric muscle activity on (18)F-FDG PET/CT.
Xavier Palard, Sébastien Carai, Pierre-Yves Le Roux, Pierre-Yves Salaün, Ronan Abgral

Clin Nucl Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment.
Philippe Robin, Ronan Abgral, Gérald Valette, Pierre-Yves Le Roux, Nathalie Keromnes, Xavier Palard

Eur J Nucl Med Mol Imaging· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of ventilation/perfusion single photon emission computed tomography for pulmonary embolism diagnosis.
Pierre-Yves Le Roux, Xavier Palard, Philippe Robin, Aurélien Delluc, Ronan Abgral

Eur J Nucl Med Mol Imaging· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma.
Ronan Abgral, Nathalie Keromnes, Philippe Robin, Pierre-Yves Le Roux, David Bourhis, Xavier Palard

Eur J Nucl Med Mol Imaging· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis